Patent classifications
A23V2250/065
Amino-acid-containing composition for enhancing recovery from muscle fatigue
Administering an amino acid-containing composition, containing the following amino acids (1)-(9), wherein the molar content ratio of each amino acid to the total content of the amino acids (1)-(9) falls within the following numerical ranges: (1) leucine 35-66%; (2) isoleucine 5.0-15%; (3) valine 5.0-15%; (4) threonine 7.0-14%; (5) lysine 8.0-16%; (6) methionine 2.0-10%; (7) histidine 0.1-3.5%; (8) phenylalanine 2.5-8.0%; and (9) tryptophan 0.1-2.0%,
is effective for enhancing recovery from muscle fatigue.
Amino-acid-containing composition for enhancing recovery from muscle fatigue
Administering an amino acid-containing composition, containing the following amino acids (1)-(9), wherein the molar content ratio of each amino acid to the total content of the amino acids (1)-(9) falls within the following numerical ranges: (1) leucine 35-66%; (2) isoleucine 5.0-15%; (3) valine 5.0-15%; (4) threonine 7.0-14%; (5) lysine 8.0-16%; (6) methionine 2.0-10%; (7) histidine 0.1-3.5%; (8) phenylalanine 2.5-8.0%; and (9) tryptophan 0.1-2.0%,
is effective for enhancing recovery from muscle fatigue.
SLEEP AID AND RELATED METHODS
A stable composition suitable for use as a sleep aid is described. The composition has, in combination: cannabinol, melatonin, magnesium glycinate, menaquinone, cholecalciferol, calcium, Vitamin E, L-Tryptophan, and gamma-aminobutyric acid.
SLEEP AID AND RELATED METHODS
A stable composition suitable for use as a sleep aid is described. The composition has, in combination: cannabinol, melatonin, magnesium glycinate, menaquinone, cholecalciferol, calcium, Vitamin E, L-Tryptophan, and gamma-aminobutyric acid.
PROTEIN ESSENTIAL AMINO ACIDS FORMULATIONS FOR HUMAN NUTRITION
This invention covers protein essential amino acids formulations as dietary supplements, nutritional formulations and foods that provide balanced and adequate levels of essential amino acid compositions to meet the recommended nutritional requirements for humans of different age groups and special need groups.
PROTEIN ESSENTIAL AMINO ACIDS FORMULATIONS FOR HUMAN NUTRITION
This invention covers protein essential amino acids formulations as dietary supplements, nutritional formulations and foods that provide balanced and adequate levels of essential amino acid compositions to meet the recommended nutritional requirements for humans of different age groups and special need groups.
PREVENTION OR REMEDIATION COMPOSITION FOR DEMENTIA OR DEPRESSION
Compositions containing one or more kinds of essential amino acids other than leucine and not less than 35 mol % of leucine, relative to the total content of essential amino acids, s are useful for preventing or improving dementia or a depressive state, in particular, a depressive state caused by stress, have high safety, and can be continuously ingested or administered.
METHOD OF SEQUENTIAL FUNGAL FERMENTATION OF LIGNEOUS RESOURCES
The present disclosure relates to a method for transforming wood residues into an edible food product for a mammal, consisting of a sequence of fungal fermentations which make it possible to render ligneous resources edible; the invention also relates to the food product obtained by this method, and to the use thereof.
METHOD OF SEQUENTIAL FUNGAL FERMENTATION OF LIGNEOUS RESOURCES
The present disclosure relates to a method for transforming wood residues into an edible food product for a mammal, consisting of a sequence of fungal fermentations which make it possible to render ligneous resources edible; the invention also relates to the food product obtained by this method, and to the use thereof.
ENERGY SUPPLEMENT
Compositions for energy supplements are provided containing L-tryptophan in an amount of 15-28%, CoQ10 in an amount of 7-15%, pyrroloquinaline quinone in an amount of 0.4-5%, niacinamide in an amount of 2-9%, niacin in an amount of 0.4-5%, magnesium in an amount of 4-20%, acetyl-L-carnitine in an amount of 10-28%, alpha liolic acid in an amount of 10-30%, N-acetyl cysteine in an amount of 4-15%, and resveratrol an amount of 3-14% administered with a daily supplement of D-Ribose in an amount of 500 mg to 15,000 mg. The compositions providing an unexpected increase in mitochondrial biogenesis, activity, and preservation and therefore increased energy availability.